Hamps Bio Limited confirmed that all three resolutions at its 19th Annual General Meeting on September 9, 2026, were passed with unanimous support. The voting results, filed with BSE Limited on September 11, 2026, show 100% approval for the adoption of FY26 financial statements and the reappointment of director Pallavi Herrik Shah.

The company’s registered office shift within Gujarat also received full backing. Promoter shareholders voted in favor of all agenda items, while public non-institutional shareholders participated via e-voting, casting votes exclusively in favor of the proposals.

Voting Participation and Results

The record date for the meeting was set as September 3, 2026, with a total of 337 shareholders eligible to vote. Of these, 11 shareholders attended the physical meeting (nine from the promoter group and two from the public). No shareholders attended via video conferencing.

E-voting was facilitated through Bigshare Services Private Limited between September 6 and September 8, 2026. The total outstanding shares stood at 8,712,000. A total of 6,728,000 shares were polled, representing 77.23% of the outstanding equity capital. All polled votes were cast in favor of the resolutions, with zero votes against or invalid.

Resolution-wise Breakdown

Promoter and promoter group holdings totaled 6,272,000 shares, all of which were voted via e-voting in favor of every resolution. Public non-institutional shareholders held 2,440,000 shares, with 456,000 shares (18.69% of this category) polled via e-voting, all in favor. No public institutional shares were recorded or voted.

Governance and Scrutiny

Herrik Mountbaton Shah, Managing Director and Chairman, presided over the meeting. The Board appointed Richa Goyal & Associates as the scrutinizer for the voting process. Richa Goyal, a practicing Company Secretary, issued her report on September 11, 2026, confirming that the resolutions were passed with the requisite majority under Section 108 and 109 of the Companies Act, 2013.

The following directors were present at the meeting:

• Herrik Mountbaton Shah (Managing Director and Chairman)
• Shrenikkumar Mountkumar Shah (Whole-time Director)
• Pallavi Herrik Shah (Director)
• Jinay Dipakkumar Palrecha (Independent Director)

Shivali Rajpurohit, Independent Director, was absent due to personal reasons. Ravi Baheti served as Company Secretary and Compliance Officer, while Mitali Shrenik Shah acted as Chief Financial Officer.

Key Resolutions Passed

Shareholders transacted all businesses mentioned in the notice dated August 12, 2026. The ordinary business included the adoption of audited standalone and consolidated financial statements for the financial year ended March 31, 2026, along with reports from the Board of Directors and auditors. Additionally, Pallavi Herrik Shah was reappointed as a director after retiring by rotation.

Under special business, members approved the shift of the registered office from one city to another within the same state of Gujarat. The move remains under the jurisdiction of the Registrar of Companies, Ahmedabad.

Hamps Bio Limited board of directors approved remuneration increases for its Chairman and Managing Director, Whole Time Director, Chief Financial Officer, and a director during a meeting held on September 9, 2026. The decisions were made based on recommendations from the Nomination and Remuneration committee.

The corporate governance move affects key leadership roles within the Gujarat-based chemical manufacturer. The board meeting commenced at 5:00 pm and concluded at 5:45 pm at the company's corporate office.

Remuneration Approvals

The board considered and approved the following changes to executive compensation:

• Increase in remuneration for Mr. Herrik Mountbaton Shah, Chairman and Managing Director (DIN: 01052316)
• Increase in remuneration for Mr. Shrenikkumar Mountkumar Shah, Whole Time Director (DIN: 00973690)
• Increase in remuneration for Mrs. Mitali Shrenikkumar Shah, Chief Financial Officer
• Approval of remuneration for Mrs. Pallavi Herrik Shah, Director (DIN: 10418931)

All approvals followed recommendations received from the Nomination and Remuneration committee.

Regulatory Disclosure

The company issued this disclosure pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The filing was signed by Ravi Baheti, Company Secretary & Compliance Officer.

Hamps Bio operates manufacturing units in Ankleshwar and Surat, Gujarat.